A novel combination therapy with Cabozantinib and Honokiol effectively inhibits c-Met-Nrf2-induced renal tumor growth through increased oxidative stress

Redox Biology - Tập 68 - Trang 102945 - 2023
Laxminarayan Rawat1,2, Murugabaskar Balan1,2, Yuzuru Sasamoto1,3,4, Akash Sabarwal1,2, Soumitro Pal1,2
1Division of Nephrology, Boston Children's Hospital, Boston, MA, USA
2Harvard Medical School, Boston, MA, USA
3Division of Genetics, Brigham and Women's Hospital, MA, USA
4Department of Ophthalmology, Boston University Chobanian & Avedisian School of Medicine, Boston, MA, USA

Tài liệu tham khảo

Thông tin
Thông tin xuất bản

Redox Biology

Tập 68

102945

Thông tin tác giả